Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

New audit system maps how mental-health risks emerge in AI chatbot conversations

Scientists have developed a framework for stress-testing how AI chatbots respond to vulnerable users, helping researchers identify weaknesses and test ways of making mental-health interactions safer.

AI could help identify patients at risk of psychosis more quickly

AI has been shown to be effective in identifying and analysing symptoms from psychiatric interviews, which could help speed up assessments and access to care for those who need it most, according to a new study.

Clinical Trial of Ketogenic Therapy for Early Psychosis funded by Baszucki Group

The University Oxford has received £1.17m of funding from Baszucki Group to assess the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P).

New psychiatry textbook by Oxford experts published

The latest edition of the Shorter Oxford Textbook of Psychiatry has just been published by Oxford University Press.

Targeted TUNE‑UP service boosts access to clozapine for patients - new paper

A new study examining the impact of an innovative clinic has highlighted its significant impact, showing a dramatic increase in the number of patients able to start clozapine safely in the community.

New study offers breakthrough in detecting risk for psychosis and bipolar disorders

A study published recently in The Lancet Psychiatry has unveiled a new approach to identifying individuals at risk of developing psychotic disorders or bipolar disorder.

Simple scoring system could help clinicians identify possible cases of NMDAR-antibody encephalitis

Scientists have identified a key set of symptoms and developed a scoring system to help clinicians in frontline medical and mental health services consider the possibility of a rare form of encephalitis, which can sometimes be mistaken for psychosis.

International study reveals brain connectivity clues to treatment-resistant psychosis

A major study has uncovered vital insights into the brain changes linked to treatment-resistant psychosis, offering fresh hope for earlier diagnosis and more targeted care.

Doctors call for improved physical health monitoring for people prescribed psychiatric medication

A major new Lancet Commission has called for people taking psychiatric medications - such as antidepressants, antipsychotics, and mood stabilisers - to receive proactive, ongoing physical health monitoring and support.

Anticholinergic medications given to people with psychosis could worsen memory

Medications routinely given to people experiencing psychosis could be worsening some of their cognitive function, including memory and concentration, according to a new analysis of existing research.

In memoriam: Professor Tim Crow OBE

The influential and pioneering psychiatric researcher Professor Timothy Crow OBE, who was a member of the Department of Psychiatry at Oxford, has died at the age of 86.

Celebrating a successful year of biomedical research with Oxford Health BRC

National Institute of Health and Care Research (NIHR) Oxford Health Biomedical Research Centre colleagues and partners gathered to share information and updates as well as celebrate progress made during the last 12 months.

Artificial intelligence (AI) language tools could be used to help detect mental health conditions

Scientists are using AI to detect language differences in people with mental health difficulties that could eventually be used to help diagnose and monitor psychiatric conditions.

New tool to streamline prescribing of antidepressants

A new web tool has been developed to simplify the prescription of antidepressant and antipsychotic drugs.

Routine brain scanning may improve clinical care for people with psychosis

Routine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, according to a new study.

Experts hold first meeting for new international project on depression, anxiety and psychosis

The Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis, or GALENOS project, has launched in central London.

Major trials to test effectiveness of cannabidiol on psychosis

Global study involving three clinical trials will investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis or psychotic symptoms, thanks to a multi-million pound grant to Oxford University.

Daniel Freeman moving to Experimental Psychology

He will be leaving the Department of Psychiatry to become Oxford's Chair of Psychology.

Dr Felicity Waite receives British Psychological Society’s May Davidson Award

The May Davidson Award recognises clinical psychologists who have made an outstanding contribution to the development of clinical psychology within the first decade of their work.

New Way of Understanding Dissociation Could Improve Patient Care

New research has developed a novel measure of dissociative experiences that share a subjective 'felt sense of anomaly'. This new approach could revolutionise how clinicians understand dissociative experiences across a range of mental health disorders, and how they work with patients with dissociation in the future.

Load More